NATCO Pharma Limited

NSE NATCOPHARM.NS

NATCO Pharma Limited Debt to Equity Ratio for the year ending March 31, 2024: 0.07

NATCO Pharma Limited Debt to Equity Ratio is 0.07 for the year ending March 31, 2024, a 92.86% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

NATCO Pharma Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.03, a -66.24% change year over year.
NATCO Pharma Limited Debt to Equity Ratio for the year ending March 31, 2022 was 0.10, a 47.10% change year over year.
NATCO Pharma Limited Debt to Equity Ratio for the year ending March 31, 2021 was 0.07, a -21.09% change year over year.
NATCO Pharma Limited Debt to Equity Ratio for the year ending March 31, 2020 was 0.09, a -21.16% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

NSE: NATCOPHARM.NS

NATCO Pharma Limited

CEO	Mr. Rajeev Nannapaneni
IPO Date	Jan. 1, 1996
Location	India
Headquarters	NATCO House
Employees	4,016
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina and CHF. The company markets its products in approximately 40 countries, including India, the United States, and internationally. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

Key trends

Past 5 years